Allworth Financial’s Cardiff Oncology CRDF Stock Holding History
Bought
Maintained
Sold
Other funds holding CRDF
VCM
LCM
P
ACA
FLPIM
Allworth Financial's CRDF Position: Q1 2026 in Review
Allworth Financial opened a new position in Cardiff Oncology (CRDF) in Q1 2026: 20 shares worth $33. The stake represents ﹤0.01% of the portfolio and ranks #5103 among its holdings. This is a return to the name: Allworth Financial previously reported a position in CRDF as recently as Q2 2025.
Allworth Financial first reported a position in CRDF in Q1 2021 and has held it in 19 quarters since. The position peaked at $9K in Q1 2021. 116 funds tracked by Wall St. Rank hold CRDF as of Q1 2026.
- Allworth Financial held 20 shares of Cardiff Oncology worth $33 as of Q1 2026.
- Cardiff Oncology was a new Allworth Financial position in Q1 2026.
- Cardiff Oncology made up ﹤0.01% of Allworth Financial's portfolio in Q1 2026, its #5103 holding.
- Allworth Financial first reported a position in Cardiff Oncology in Q1 2021 and has held it in 19 quarters since.
- Allworth Financial's Cardiff Oncology position peaked at $9K in Q1 2021.
- 116 funds tracked by Wall St. Rank held Cardiff Oncology as of Q1 2026.
Based on Allworth Financial's 13F filing for Q1 2026, filed 15 May 2026.